Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Charbonnel BH, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Saraiva GL, Medina J, Nicolucci A, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K; DISCOVER Investigators.
Charbonnel BH, et al. Among authors: cid ruzafa j.
Diabetes Obes Metab. 2023 Jan;25(1):46-55. doi: 10.1111/dom.14842. Epub 2022 Sep 16.
Diabetes Obes Metab. 2023.
PMID: 36111434
Free PMC article.